Lipid biosynthesis perturbation impairs endoplasmic reticulum-associated degradation

J Biol Chem. 2023 Aug;299(8):104939. doi: 10.1016/j.jbc.2023.104939. Epub 2023 Jun 17.

Abstract

The relationship between lipid homeostasis and protein homeostasis (proteostasis) is complex and remains incompletely understood. We conducted a screen for genes required for efficient degradation of Deg1-Sec62, a model aberrant translocon-associated substrate of the endoplasmic reticulum (ER) ubiquitin ligase Hrd1, in Saccharomyces cerevisiae. This screen revealed that INO4 is required for efficient Deg1-Sec62 degradation. INO4 encodes one subunit of the Ino2/Ino4 heterodimeric transcription factor, which regulates expression of genes required for lipid biosynthesis. Deg1-Sec62 degradation was also impaired by mutation of genes encoding several enzymes mediating phospholipid and sterol biosynthesis. The degradation defect in ino4Δ yeast was rescued by supplementation with metabolites whose synthesis and uptake are mediated by Ino2/Ino4 targets. Stabilization of a panel of substrates of the Hrd1 and Doa10 ER ubiquitin ligases by INO4 deletion indicates ER protein quality control is generally sensitive to perturbed lipid homeostasis. Loss of INO4 sensitized yeast to proteotoxic stress, suggesting a broad requirement for lipid homeostasis in maintaining proteostasis. A better understanding of the dynamic relationship between lipid homeostasis and proteostasis may lead to improved understanding and treatment of several human diseases associated with altered lipid biosynthesis.

Keywords: Doa10; ER quality control; Hrd1; Saccharomyces cerevisiae; endoplasmic reticulum-associated degradation (ERAD); phospholipid metabolism; protein degradation; sterol; translocon quality control; yeast genetics.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Drug Resistance, Fungal / genetics
  • Endoplasmic Reticulum-Associated Degradation* / genetics
  • Hygromycin B / pharmacology
  • Lipids* / biosynthesis
  • Mutation
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / metabolism
  • Saccharomyces cerevisiae Proteins* / genetics
  • Saccharomyces cerevisiae Proteins* / metabolism

Substances

  • Anti-Infective Agents
  • DEG1 protein, S cerevisiae
  • Hygromycin B
  • INO2 protein, S cerevisiae
  • INO4 protein, S cerevisiae
  • Lipids
  • Saccharomyces cerevisiae Proteins
  • SEC62 protein, S cerevisiae